Search Results for Victoza

Showing 1 – 4

FDA Denies Novo Nordisk Petition on Liraglutide Generics By Zachary Brennan - Published 08 January 2018

The US Food and Drug Administration (FDA) on Friday denied Novo Nordisk’s citizen petition that aimed to block generic versions of its blockbuster Victoza (liraglutide) and two other products containing liraglutide.

Categories: News, US, FDA, Drugs, Regulatory intelligence, Regulatory strategy, Submission and registration

Tags: liraglutide, citizen petition, Victoza generic

Novo Nordisk Pays $58M to Settle REMS Allegations By Michael Mezher - Published 06 September 2017

Danish drugmaker Novo Nordisk on Tuesday agreed to pay $58 million to settle allegations that the company failed to follow the risk evaluation and mitigation strategy (REMS) for its blockbuster diabetes drug Victoza (liraglutide).

Categories: News, US, DOJ, FDA, Advertising and Promotion, Communication, Drugs

Tags: Novo Nordisk, Victoza, REMS

Public Citizen Again Calls for Ban on Diabetes Drug Victoza By Alexander Gaffney, RAC - Published 06 June 2014

A prominent consumer watchdog group is calling on the US Food and Drug Administration (FDA) to withdraw its approval of the diabetes drug Victoza (liraglutide), which it says is linked to acute pancreatitis and several deaths.

Categories: News, US, CDER, Drugs, Postmarket surveillance, Product withdrawl and retirement

Tags: Novo Nordisk, Victoza, GLP-1, Public Citizen, Petition, Safety

Public Citizen to FDA: Diabetes Drug Unsafe, Should Be Pulled By Alexander Gaffney - Published 20 April 2012

Categories: FDA

Tags: Rosebraugh, Liraglutide, Victoza, Diabetes, Novo Nordisk, Wolfe, Public Citizen, Latest News, risks